RadNet, Inc. · NASDAQ:RDNT

RadNet — Investor Presentation (February 2010)

23 slides from RadNet's investor presentation, February 2010

  1. Slide 1: February 2010 NASDAQ: RDNT

    February 2010 NASDAQ: RDNT

  2. Slide 2: Safe Harbor

    Safe Harbor This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning the benefits of the merger of Primedex Health Systems, Inc. and Radiologix, Inc. to form RadNet, Inc., expected syner

  3. Slide 3: Presenters

    Presenters Howard Berger, M.D. President and Chief Executive Officer Mark Stolper Executive Vice President and Chief Financial Officer 2

  4. Slide 4: I. Introduction

    I. Introduction II. Diagnostic Imaging Industry Overview III. Overview of RadNet IV. Financial Information and Core Strategy 3

  5. Slide 5: RadNet Summary

    RadNet Summary  Largest national owner and operator of fixed-site diagnostic imaging centers, with 175 locations  Founded as a one center CA operation in 1984  Largest fixed-site medical imaging center company in the U.S.  Have emerged as the fastest growing consolidator in the highly fragmented

  6. Slide 6: RadNet Summary (cont.)

    RadNet Summary (cont.)  Only imaging center player to provide exclusive managed care capitation arrangements with prominent medical groups and Independent Physician Associations (IPAs)  Provides “ sticky”and predictable revenue base and substantial “ pull-through”business  Over 750,000 lives mana

  7. Slide 7: I. Introduction

    I. Introduction II. Diagnostic Imaging Industry Overview III. Overview of RadNet IV. Financial Information and Core Strategy 6

  8. Slide 8: Diagnostic Imaging: A Large and Growing Market

    Diagnostic Imaging: A Large and Growing Market  National imaging market is estimated at $100 billion  Highly fragmented industry  Approximately 6,000 outpatient diagnostic imaging centers in the US  Advanced imaging procedures growing quickly  MRI and CT: 3%-5% CAGR  PET/CT: >5% CAGR  Demand

  9. Slide 9: Types of Imaging Exams "Modalities"

    Types of Imaging Exams “Modalities” MRI –Produces high Nuclear Medicine – resolution cross- Producers images of sectional images of soft anatomical structures. tissue. Applications: Applications: Assesses brain, spinal cord and organ function in heart, interior ligaments. kidney, thyroid and bones.

  10. Slide 10: DRA and Credit Crises Are Driving Consolidation

    DRA and Credit Crises Are Driving Consolidation  Deficit Reduction Act of 2005 (“ DRA” ) went into effect on January 1, 2007  Primarily impacted Medicare reimbursement for MRI, CT, and PET/CT modalities  Lower Medicare reimbursement has made it difficult for “ mom-and-pop”operators  Not well cap

  11. Slide 11: I. Introduction

    I. Introduction II. Diagnostic Imaging Industry Overview III. Overview of RadNet IV. Financial Information and Core Strategy 10

  12. Slide 12: We are Regionally Focused

    We are Regionally Focused 175 facilities located predominantly in the concentrated markets of California, Maryland, Delaware, New Jersey and New York NY 19 NJ –8 DE - 12 CA KS 97 2 MD - 34 FL 3 11

  13. Slide 13: Multi-Modality Focused

    Multi-Modality Focused  The vast majority of our centers are multi-modality  Extensive offering of routine imaging procedures partially insulates us from reimbursement cuts, which generally affect (like the DRA) MRI, CT and PET modalities disproportionally Scan Scan Volume Volume by by Modality Mo

  14. Slide 14: Diversified Payor Mix

    Diversified Payor Mix  Exclusive capitation business decreases the Combined Company’ s exposure to potential pricing changes from commercial payors  Capitation dilutes the % of our business from each of the other payor classes  Capitation price escalators create “ built in”increasing reimbursemen

  15. Slide 15: Capitated Contracts Create a Barrier to Entry

    Capitated Contracts Create a Barrier to Entry  RadNet has over 25 capitated contracts with California physician groups representing approximately 15% of our revenue  We receive a per-member-per-month fixed price for exclusively providing outpatient imaging to over 750,000 lives in CA  Exclusive n

  16. Slide 16: RadNet's BreastLink: Breast Disease Management

    RadNet’ s BreastLink: Breast Disease Management  Acquired renowned specialty breast medical oncology and breast surgery practices in Southern California  Imaging is an integral part of identifying, diagnosing, staging and tracking the progression of breast cancer  BreastLink provides patients wit

  17. Slide 17: Experienced Management Team

    Experienced Management Team Howard Berger, MD –Chairman and Chief Executive Officer Mark Stolper –Chief Financial Officer Co-founded RadNet in 1981 Deep experience in investment banking and private Over 25 years of experience in the equity development and management of Dillon Read investment ban

  18. Slide 18: I. Introduction

    I. Introduction II. Diagnostic Imaging Industry Overview III. Overview of RadNet IV. Financial Information and Core Strategy 17

  19. Slide 19: Strong Revenue and EBITDA Performance

    Strong Revenue and EBITDA Performance Revenue EBITDA Trailing 12 Mo. Revenue = $523.3mm Trailing 12 Mo. EBITDA = $102.9mm* * Adjusted for $1.5mm non-cash charge for increasing the contractual allowance on Accounts Receivable from services provided in 2008 and prior fiscal years. Adjustment occurred

  20. Slide 20: Strong Year to Date Performance

    Strong Year to Date Performance Revenue EBITDA * * +6.1%Growth +5.9%Growth  Revenue increased 6.1% to $394.1* million vs. $371.4 million for the 9 months of 2008  Adjusted EBITDA increased 5.9% to $80.4* million vs. $75.9 million for the 9 months of 2008  MRI volume increased 9.9%, CT volume incr

  21. Slide 21: Elements of Core Strategy

    Elements of Core Strategy  Focus on free cash flow generation and deleveraging the balance sheet  Continue to drive growth through marketing, contracting and newer initiatives such as mammography and women’ s health  Continue to complete very accretive tuck-in acquisitions  Many underperforming

  22. Slide 22: Summary Valuation Metrics: RDNT

    Summary Valuation Metrics: RDNT Valuation Metrics Based Upon Anticipated 2009 EBITDA 1 Equity Market Capitalization @ $2.19 per share $ 79.2 mm 2 Net Debt 456.1 mm Current Enterprise Valuation $ 535.3 mm Trailing 12 Mo. EBITDA - 9/30/09 $ 102.9 mm* 2009 RadNet EBITDA Guidance $105-110 mm Enterprise

  23. Slide 23: Summary: Near Term Outlook is Encouraging

    Summary: Near Term Outlook is Encouraging  # of scans in industry is projected to continue to grow  Abundant consolidation opportunities at attractive multiples  Advantages of RadNet’ s scale and cost structure are becoming more important  Weaker competitors beginning to close  RadNet has a lea

RadNet — Investor Presentation (February 2010) on 6ix